BBP.US Virtus LifeSci Biotech Products ETF

- USD
No recent price
Total assets
135M
Expense ratio
0.77%
Dividend yield
-
1-year return
+35.57%
Holdings
65
Since
2014

Fund data as reported by the issuer, updated Nov 14, 2026. Total assets are in the fund's base currency.

What does BBP.US invest in?

  • Mostly US stocks (96.6%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (98.8%)
  • Top 3 holdings: 12.5% of the fund

Asset allocation

  • US stocks 96.6%
  • Non-US stocks 4.8%
  • Cash 0.2%

Top holdings

  • Moderna Inc 6.64%
  • Xeris Pharmaceuticals Inc 2.98%
  • Verastem Inc 2.85%
  • Omeros Corporation 2.53%
  • Iovance Biotherapeutics Inc 2.53%
All holdings, sectors and regions

Virtus LifeSci Biotech Products ETF performance

Sharpe ratio 1.27
This year
+31.02%
1 year
+35.57%
3 years
+30.47%
5 years
+16.40%

Volatility 17.2% over 1 year and 17.9% over 3 years. Moderate, similar to a broad stock index.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

BBP.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About Virtus LifeSci Biotech Products ETF

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration (FDA) for marketing.

Full fund profile